Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noam Levaot

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cell Calcium|August 27, 2018
How cellular Zn<sup>2+</sup> signaling drives physiological functionsNoam Levaot, Michal Hershfinkel
New Biotechnology|May 7, 2026
Multi-specific targeting of CD44 and the catalytic and hemopexin domains of MMP9 as a therapeutic strategy for osteoclast inhibitionDan Pasternak, Shani Ohayon, Noam Levaot, et al.
Cellular and Molecular Life Sciences : CMLS|January 31, 2022
Competitive blocking of LRP4-sclerostin binding interface strongly promotes bone anabolic functionsSvetlana Katchkovsky, Biplab Chatterjee, Chen-Viki Abramovitch-Dahan, et al.
The Journal of Biological Chemistry|September 12, 2015
Combinatorial and Computational Approaches to Identify Interactions of Macrophage Colony-stimulating Factor (M-CSF) and Its Receptor c-FMSLior Rosenfeld, Jason Shirian, Yuval Zur, et al.
Journal of Cellular Physiology|March 24, 2017
Dual-specificity tyrosine phosphorylation-regulated kinase 2 regulates osteoclast fusion in a cell heterotypic mannerGali Guterman-Ram, Milena Pesic, Ayelet Orenbuch, et al.
FEBS Letters|October 23, 2024
Mapping the sclerostin-LRP4 binding interface identifies critical interaction hotspots in loops 1 and 3 of sclerostinSvetlana Katchkovsky, Reut Meiri, Shiran Lacham-Hartman, et al.
Biomaterials|March 23, 2019
Reconstruction of the ovary microenvironment utilizing macroporous scaffold with affinity-bound growth factorsShani Felder, Hila Masasa, Ayelet Orenbuch, et al.
Bone|May 27, 2015
Osteoclast fusion is initiated by a small subset of RANKL-stimulated monocyte progenitors, which can fuse to RANKL-unstimulated progenitorsNoam Levaot, Aner Ottolenghi, Mati Mann, et al.
Scientific Reports|August 31, 2018
Schlafen2 mutation in mice causes an osteopetrotic phenotype due to a decrease in the number of osteoclast progenitorsIbrahim Omar, Gali Guterman-Ram, Dolev Rahat, et al.
International Journal of Biological Macromolecules|October 24, 2024
Preventing osteoporotic bone loss in mice by promoting balanced bone remodeling through M-CSF<sub>RGD</sub>, a dual antagonist to c-FMS and αvβ3 receptorsYuval Zur, Svetlana Katchkovsky, Amit Itzhar, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cell Calcium|August 27, 2018
How cellular Zn<sup>2+</sup> signaling drives physiological functionsNoam Levaot, Michal Hershfinkel
New Biotechnology|May 7, 2026
Multi-specific targeting of CD44 and the catalytic and hemopexin domains of MMP9 as a therapeutic strategy for osteoclast inhibitionDan Pasternak, Shani Ohayon, Noam Levaot, et al.
Cellular and Molecular Life Sciences : CMLS|January 31, 2022
Competitive blocking of LRP4-sclerostin binding interface strongly promotes bone anabolic functionsSvetlana Katchkovsky, Biplab Chatterjee, Chen-Viki Abramovitch-Dahan, et al.
The Journal of Biological Chemistry|September 12, 2015
Combinatorial and Computational Approaches to Identify Interactions of Macrophage Colony-stimulating Factor (M-CSF) and Its Receptor c-FMSLior Rosenfeld, Jason Shirian, Yuval Zur, et al.
Journal of Cellular Physiology|March 24, 2017
Dual-specificity tyrosine phosphorylation-regulated kinase 2 regulates osteoclast fusion in a cell heterotypic mannerGali Guterman-Ram, Milena Pesic, Ayelet Orenbuch, et al.
FEBS Letters|October 23, 2024
Mapping the sclerostin-LRP4 binding interface identifies critical interaction hotspots in loops 1 and 3 of sclerostinSvetlana Katchkovsky, Reut Meiri, Shiran Lacham-Hartman, et al.
Biomaterials|March 23, 2019
Reconstruction of the ovary microenvironment utilizing macroporous scaffold with affinity-bound growth factorsShani Felder, Hila Masasa, Ayelet Orenbuch, et al.
Bone|May 27, 2015
Osteoclast fusion is initiated by a small subset of RANKL-stimulated monocyte progenitors, which can fuse to RANKL-unstimulated progenitorsNoam Levaot, Aner Ottolenghi, Mati Mann, et al.
Scientific Reports|August 31, 2018
Schlafen2 mutation in mice causes an osteopetrotic phenotype due to a decrease in the number of osteoclast progenitorsIbrahim Omar, Gali Guterman-Ram, Dolev Rahat, et al.
International Journal of Biological Macromolecules|October 24, 2024
Preventing osteoporotic bone loss in mice by promoting balanced bone remodeling through M-CSF<sub>RGD</sub>, a dual antagonist to c-FMS and αvβ3 receptorsYuval Zur, Svetlana Katchkovsky, Amit Itzhar, et al.
Pageof 3